]]> Remember The Miners Declares Inaugural Bob Huggins Tailgate a ‘Tremendous Success'

Governor Tomblin, state leaders attend celebration of West Virginia’s miners

(PRWEB) January 23, 2012

Remember The Miners, the non-profit public awareness campaign dedicated to telling the story of America’s real source of energy – the coal miner – is excited to announce it eclipsed its fundraising goal of $40,000 for the event. Proceeds of the event benefit both Remember The Miners Scholars Program and the Norma Mae Huggins Cancer Research Endowment Fund at West Virginia University.

The event, which was held at the Loyal Order of Moose Lodge 1444 in Charleston, WV, attracted many folks to celebrate coal mining in West Virginia and pay tribute to Remember The Miners’ Honorary Chairman and WVU Men’s Basketball Coach Bob Huggins. Among those attending were West Virginia Governor Earl Ray Tomblin, members of the state House and Senate, and former Mountaineer standout John Flowers.

“It was a great night to celebrate West Virginia and raise money for two wonderful causes that mean a great deal to me. It’s great to give our fans, coal mining supporters, and West Virginians the chance to come out, have fun, and raise money. We’ve had two great events and we’re going to keep going,” said Huggins.

The event featured West Virginia musical talent Taylor Made, who performed their signature song, “West Virginia Underground.”

“The Huggins Tailgate was a great success,” began Jason Parsons, President of Remember The Miners. “With the support of Coach Huggins and community partners like Little General, we exceeded our fundraising goal. We’ll use these funds to continue providing scholarships and raising awareness for the good the mining industry does for West Virginia and America.”

The Bob Huggins Tailgate netted $50,000 for Remember The Miners and the Norma Mae Huggins Cancer Research Endowment Fund.

For more information and updates about Remember The Miners, please visit Remember The Miners on Facebook or visit http://www.remembertheminers.org.

About Little General
Beckley, West Virginia-based Little General Store, owned by Greg Darby and Cory Beasley, operates 85 convenience stores and 15 freestanding restaurants. The company is a franchisee for 28 Subways, 15 Godfather’s Pizzas, 11 Sam’s Hot Dog Stands, seven Burger Kings, six Arbys, four Taco Bells, three Krispy Krunchy Chicken Stands, two Steak Escapes and the 79er Restaurant in Burnsville, West Virginia. For more information, see http://lgstores.com/.

About Remember The Miners
Remember The Miners is a public awareness campaign dedicated to telling the story of America’s real source of energy: the coal miner. Remember The Miners builds valued partnerships to raise awareness through events, media, and the Remember The Miners Scholars Program.

]]> NexCore Group Breaks Ground on Medical Office Building for Saint Agnes Hospital in Baltimore

MOB an integral part of the hospital’s $200 million campus revitalization plan

Baltimore, MD and Denver, CO (PRWEB) November 08, 2011

NexCore Group LP, a top-ranked national healthcare real estate developer, has broken ground on an 80,000 square foot medical office building (MOB) on the campus of Saint Agnes Hospital in Baltimore. The ground break is NexCore’s third of 2011.

NexCore is developing the $24 million MOB in collaboration with Saint Agnes Hospital — a 298-bed, full-service teaching hospital with residency programs in medical and surgical specialties. Saint Agnes is a member of Ascension Health, the largest non-profit healthcare organization in the country.

The new MOB is part of the hospital’s $200 million master plan to enhance and expand its campus. The campus revitalization will create 550,000 square feet of new facilities and patient-friendly, integrated environments that better serve the hospital’s growing patient base. Major progress on the revitalization plan has been completed over the past three years, including the campus centerpiece, a new 200,000 square foot patient tower with 120 private rooms.

The four-story MOB will be connected to the hospital on multiple levels and will have its own patient-dedicated surface parking. The facility will house independent and hospital-employed physician groups as well as growing hospital programs such as the Cancer Institute and Cardiovascular Institute. The Cancer Institute at Saint Agnes was recently awarded the highest accreditation possible for a cancer program from the Commission on Cancer, an accreditation level that has been bestowed on only 14 percent of the nation’s hospitals.

“We are excited about the new medical office building, which is our first on-campus medical office development in over 20 years,” says Bonnie Phipps, President & CEO of Saint Agnes. “We view the new facility as an integral part of our campus revitalization. It will provide our patients and medical staff with a modern, conveniently located ambulatory care center and will also allow our Cancer Institute to expand its capacity by 40 percent.”

“We’ve definitely had our challenges on this project, and NexCore has responded with flexibility and creativity every step of the way,” says Ms. Phipps. “For example, NexCore was willing to redesign the MOB late in the pre-development process to help us attract more physicians to our campus. We value a developer that puts the hospital’s strategic objectives first.”

“We are proud to develop and own this important building,” says Jarrod Daddis, Executive Managing Director at NexCore. “The new building will provide space for state-of the-art outpatient services in oncology, cardiology, thoracic, urology, pulmonology and hepatology and will provide growth for more providers. It is exciting to be a part of the history and future of healthcare at Saint Agnes Hospital.”

NexCore Group is providing a full spectrum of healthcare real estate services for the MOB project, including strategic planning, development, financing, leasing and management.

About NexCore Group LP

NexCore Group delivers comprehensive healthcare real estate solutions for hospitals, healthcare systems, and physician partners across the United States. Recognized by Modern Healthcare as one of the Top 20 Healthcare Real Estate Developers since spinning off from its predecessor company in 2004, NexCore has become one of the nation’s most active and respected healthcare developers. NexCore has grown its operating platform, expanded with regional offices, and increased its portfolio of developed, acquired, and managed projects to include nearly 5.2 million square feet of facilities, with nearly 1.8 million square feet currently under management. NexCore is headquartered in Denver, with offices in Chicago and Bethesda, Md. For more information, please visit http://www.nexcoregroup.com. Contact: Tracy Hindman, Marketing Director, 303-244-0700.

Fact Sheet

Saint Agnes Hospital Medical Office Building
http://www.nexcoregroup.com/in-development/SaintAgnesHospitalMOB

Location: 3407 Wilkens Ave., Baltimore, Md. 21229 (on the Saint Agnes Hospital Campus)

Size: Four levels, 80,000 square feet

Construction Start: October 2011

Planned Occupancy: October 2012

Client: Saint Agnes Hospital, Baltimore (member of Ascension Health)

Developer: NexCore Group LP, Denver

Owner: The project is being financed and will be owned by NexCore Group

Architect: RTKL, Baltimore and Washington D.C.

Construction Manager: Whiting-Turner Contracting Company, Baltimore

Property Manager: NexCore Properties LLC, Denver

Asset Manager: NexCore Properties LLC, Denver

]]> Celebrate a Greener Cyber Monday with Sustainable Skincare Company Marie Veronique Organics

Shop Green and Save Green on Award-Winning MVO Skincare Made from Natural, Organic and Fair Trade Ingredients Packaged in 100% Recyclable Materials.

Berkeley, CA (PRWEB) November 25, 2011

For most people, Cyber Monday has become the holy grail of holiday shopping—the coveted deals day that also allows consumers to be a smarter, green shopper. On November 28, to celebrate the holiday season’s busiest online shopping day, natural skincare company Marie Veronique Organics is offering 25% off their entire line of award-winning products.

Sourced as close as possible to their Berkeley headquarters, MVO products are not only made with natural, organic and fair trade ingredients packaged in 100% recyclable materials—you’ll never find toxins, petroleum-based products, nanoparticles, or anything else that’s potentially harmful.

“MVO’s skincare products are not exclusive to those who live in the Bay Area,” said Hillary Peterson, CEO of Marie Veronique Organics. “MVOrganics.com allows you to shop comfortably from home and have natural skincare from a sustainable, thoughtful company delivered right to your door.”

Savings will begin midnight on Sunday (November 27) and continue through Cyber Monday, November 28, 2011. All products purchased during this time will receive the 25% off discount, when special offer code CyberMonday is entered at checkout.

Founder and former chemistry teacher, Marie Veronique Nadeau, believes science and nature have a good thing going. In creating her products Marie uses scientific studies and direct research to better understand skin, turning to nature to find ingredients to minimize and counter those effects.

Marie Veronique Organics is recognized by the Environmental Working Group as one of the safest skin care lines on the market and is a proud singer of the Compact for Safe Cosmetics. Most recently, MVO’s Moisturizing Face Screen has won the coveted Beauty Bible’s Anti-Ageing Award for Best Tinted Moisturizing with SPF.

ABOUT MARIE VERONIQUE ORGANICS: As a former chemistry teacher, Marie developed Marie Veronique Organics with her daughter, physicist Dr. Jay Nadeau. Marie’s goal was to create a skincare line that would allow her to age gracefully and naturally. “We are honored to provide you with the smartest anti-aging products on the market. We have a deep scientific understanding of the aging process and we look to nature to provide ingredients that will nourish the skin and aid in slowing down the aging process”, says Marie.

Marie Veronique Organics operates responsibly and sustainably, sourcing fair trade, organic, and/or locally grown whenever possible, and using biodegradable ingredients, labels, and easily recyclable packaging. Ten percent of company profits are donated annually to support the environment and create better opportunities for women and children in Third World countries.

Marie Veronique Organics’ award-winning facials are available in select spas including:
– Solage, voted #1 spa in the Americas and Caribbean by Conde Nast Traveler readers.
– The Inn at Palmetto Bluff, recognized by Travel + Leisure as the #1 spa in the U.S.
– Esperanza, recognized by Travel + Leisure as the #1 spa in Mexico.

]]> Simmons Firm Investigates Type 2 Diabetes Drug Linked to Bladder Cancer

Actos taken for a prolonged time period and at a high dosage has an increased risk of bladder cancer, FDA warns.

Alton, IL (PRWEB) September 21, 2011

Simmons Browder Gianaris Angelides & Barnerd LLC is currently investigating claims that Actos, a drug manufactured by Takeda Pharmaceuticals to treat type 2 diabetes, can increase the risk of developing bladder cancer.

Actos, FDA approved in 1999, is a drug that contains the active ingredient pioglitazone hydrochloride, a type of thiazolidinedione or glitazone. The drug works to reduce blood glucose levels by increasing the sensitivity of the liver, fat and muscle cells to insulin, a hormone that is produced by the pancreas which is either underprovided or absent in diabetes patients.

On June 15, 2011, the FDAinformed the public through a drug safety communication that “use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer.”

This FDA information is based on a review of data from a planned five-year interim analysis of an ongoing ten-year study. A similar study conducted in France has already led to the suspension of Actos in both France and Germany.

In addition to the increased risk of bladder cancer, FDA drug and safety warnings also indicate that other Actos side effects can include an increased risk of: congestive heart failure (CHF), rare but serious liver problems, and bone fractures.

“While the safety warnings on Actos will be updated, that is still too late for the many people who’ve taken Actos to treat type 2 diabetes and were unaware of its long-term effects,” said Trent Miracle, Simmons Firm Partner who is leading the investigation.

If you are currently taking Actos, discuss risks and benefits with your doctor. Do not stop taking any medication until you have discussed this information with your health care provider.

The Actos lawyers at the Simmons Law Firm are currently investigating claims against Actos. Learn more information from these Actos lawyers.

About Simmons Browder Gianaris Angelides & Barnerd LLC
The Simmons Firm is a leading law firm in pharmaceutical litigation. The Simmons firm has experience in litigating complex medical matters and has taken a leadership role in standing up for individuals who have been injured by dangerous or defective drugs. The firm has represented thousands of pharmaceutical clients and recovered more than $230 million in verdicts and settlements. Learn more at http://www.simmonspharmalaw.com.

]]> Active CC Boxes Becomes Intelligent Thermal Solutions, Powered by New Leadership Team; Kodiak Cold Chain Containers for Pharmaceuticals and Biologics Re-branded as EcoTherm

U.S. maker of five-day temperature-assured and eco-friendly cold chain containers for safely shipping pharmaceuticals and biologics worldwide changes corporate name and rebrands products; announces new leadership team.

Kingsvile, TX (PRWEB) August 01, 2011

Active CC Boxes LLC, U.S. maker of five-day temperature-assured and eco-friendly cold chain containers for safely shipping pharmaceuticals and biologics worldwide, announces a corporate name change to Intelligent Thermal Solutions, LLC, effective immediately.

The new name is supported by a new logo and corporate identity that better reflects the company’s products and reputation, and a rebranding of its products to articulate client benefits.

In addition, a new corporate leadership team selected to implement new market and business development strategies includes:    
    President and Chief Executive Officer Richard C. Ellinger, formerly a Chicago-based cold chain consultant and principal at Temperature Assurance Group, and former Global Director of Marketing and Business Development at ThermoSafe Brands. Mr. Ellinger is an expert in healthcare cold chain issues, regulations and compliance, specializing in strategic business development. He holds an MBA from the University of Notre Dame, and is an Executive Advisory Board member and trainer for IQ Pharma’s International Healthcare Conferences. He has also served as a board member for the Alliance of Foam Packaging Recyclers.     Chief Operating Officer and Chief Technology Officer John V.W. Howe, formerly Active CC Boxes CEO. Mr. Howe is an authority on the physics of cold chain container design, and U.S. patent- holder. He authors a blog on Cold Chain issues in the pharma and biotech industries, at http://coldchain.cc/     Account Executive Steven R. Kaplan, who was previously a sales executive at Tegrant Diversified Brands. He began his career with Polyfoam Packers Corporation, becoming General Managing Partner.

Aligned with the corporate name change, products formerly known as the Kodiak ATA R36, D36 and R11 containers are now branded as EcoTherm™ R36, D36 and R11. Each container uses the patented IntelliTherm™ technology for precise temperature maintenance over a five-day shipping period, the best in the industry. Using EcoTherm™ containers, pharmaceutical and biologics clients can ship for less cost worldwide with assurance of product efficacy in highly-variable ambient conditions, and the satisfaction that the containers are environmentally-friendly with no disposal or recycling necessary.

“The EcoTherm™ brand name reflects both the environmentally-friendly nature of our containers, and their outstanding ability to hold specific temperature requirements through extended durations,” explained Mr. Ellinger. “Our customers want a greener solution than the current consumable insulated containers in the market today. They also want extended hold time and increased payload. EcoTherm™ containers satisfy all of these important customer needs.”

The science behind EcoTherm™ containers is based on vacuum-insulated panels, an IntellTherm™ temperature regulator, and a Thermal Shield™ , unique in the industry, to ensure the integrity of temperature-critical payloads shipped globally. The container minimizes temperature stratification and maximizes payload volume. Rugged EcoTherm™ containers are reusable for years, so do not contribute profusely to landfills like typical corrugated boxes with polystyrene or urethane insulation.

Intelligent Thermal Solutions’ products are:
    The R36, the flagship of the EcoTherm line, with a 36-liter payload capacity – more than four times the volume of typical disposable cold chain containers for their size. A patented thermal regulating lid controls the temperature of the payload between 2 and 8 degrees Celsius for more than five days with no power or ice. An optional freeze rack accelerates the freeze time of the R36 lid to under 24 hours, through the use of forced-air convection.     The D36, for customers who ship frozen materials. The D36 is a unique dry ice container with super insulation and reduced dry ice needs. The D36 will maintain temperatures below minus 50 degrees Celsius for up to 5 days, based on the amount of dry ice in the unit, with 36 cubic liters for dry ice and cargo.     The R11, an 11-liter container which uses the IntelliTherm™ patented technology to maintain 2 – 8 degrees Celsius for more than five days. Its single-handle carry design makes the container excellent for clinical trials, organ transport and smaller shipments.     FiberFlow packing material, an excellent cushioning product that enables free-flow of air within the cargo area. FiberFlow can be easily customized for specific products packed into an EcoTherm container.     

In addition to purchasing programs, ITS offers customers a convenient rental program at less cost than purchasing competitive passive systems. The receiver of the shipment simply returns the rented containers to depots in New Jersey and Mainz, Germany. New containers arrive on-demand at the customer’s location, fully prepared for loading and shipping. Long term leasing programs are also available for the EcoTherm™ units.

For more information about Intelligent Thermal Solutions products, call 1+ (888) 465-6342, or visit http://www.intelligentthermalsolutions.com.

About Intelligent Thermal Solutions
Intelligent Thermal Solutions is a south Texas company headquartered in Kingsville, TX previously known as Active CC Boxes LLC. ITS manufactures reusable cold chain shipping containers with extended hold times meeting the unique safety needs of pharmaceutical and biologics companies. EcoTherm™ containers overcome the cumbersome limitations of corrugated boxes lined with polystyrene or urethane insulation and filled with dry ice or frozen gel packs. The technology in EcoTherm™ containers was recognized in 2002 with the Dupont Gold Award for packaging design innovation for cold chain, and the 2002 R&D 100 Awards recognizing the 100 most technologically-significant products of 2002.

]]> ProPep Surgical™ Issued Unites States Patent for its ProPep Nerve Monitoring System™

The ProPep Nerve Monitoring System™ is the first, real-time nerve identification system specifically designed for use during robotic surgery

(PRWEB) January 12, 2012

ProPep Surgical, LLC, a privately-held, Austin-based medical device company, announced today the United States Patent and Trademark Office has granted the company a patent for a System and Method for Laparoscopic Nerve Detection (8,083,685). This is the first in a series a patents the Company has filed or will be filing on their ground breaking ProPep Nerve Monitoring System.

The ProPep Nerve Monitoring System is the first, real-time nerve identification system specifically designed for use during robotic surgery. Fast, accurate and easy to use, the System aids a surgeon in identifying otherwise invisible nerves during minimally invasive robotic pelvic surgery.

“Currently, surgeons rely on anatomic landmarks to identify these nerves during surgery.  Unfortunately, these landmarks are not always reliable,” according to Dr. Randy Fagin, Chief Medical Officer.  “By helping the surgeon identify these nerves in real-time during the surgical procedure, the ProPep Nerve Monitoring System allows the surgeon to make a more informed decision about which tissue to selectively preserve or remove during an operation and as a result, potentially reduce the incidence of nerve damage related side effects such as incontinence and sexual dysfunction following prostatectomy surgery.” 

“We are very excited about the issuance of the Company’s first patent,” stated Jim Schneider, Chief Operating Officer. “It is an important milestone for the Company and is the foundation upon which ProPep is building its Nerve Monitoring System intellectual property estate. We look forward to continued success in the development and commercialization of our technology, and to ultimately providing robotic surgeons the same nerve monitoring capabilities that have been Standard of Care in multiple open surgical procedures for decades.”        

About ProPep Surgical, LLC
Established in 2010, ProPep Surgical is a privately-held, Austin-based medical device company developing a system of products (ProPep Nerve Monitoring System) to aid robotic surgeons in identifying otherwise invisible nerves during minimally invasive robotic surgery. Real time identification of these nerves will allow the surgeons to make a more informed decision about which tissue to selectively preserve or remove during prostatectomies, hysterectomies and colorectal surgery and as a result, potentially reduce the common side effects typically attributed to inadvertent nerve damage during these robotic surgical procedures.

]]> Medical Office Building Deals and New Development Might be on the Rise

New edition of the Healthcare Real Estate Insights newsletter details dozens of recent sales transactions and new projects in multiple markets nationwide

MINNEAPOLIS (PRWEB) July 29, 2011

The level of healthcare real estate sales transaction and development activity seems to be increasing, if the most recent edition of Healthcare Real Estate Insights is any indication. Eleven medical office building (MOB) sales transactions, a dozen new outpatient developments and 10 inpatient projects are detailed in the current edition of HREI, a national healthcare real estate publication based in Minneapolis.

Some of the major deals include:
? American Realty Capital Healthcare Trust Inc., a non-traded real estate investment trust (REIT), plans to acquire medical properties totaling 765,038 square feet at multiple locations for a price of $257.5 million.
? Healthcare Trust of America Inc., another non-traded REIT, announced that it has entered a purchase agreement to acquire the Desert Ridge Medical Campus in Phoenix for $32.75 million.
? Grubb & Ellis Healthcare REIT II has closed on the $7.2 million acquisition of a 41,000 square foot MOB on the campus of Doctors Hospital in Sarasota, Fla.

Some new MOB and other outpatient developments described in the current edition of HREI include:
? A group of physicians in the western Philadelphia suburb of Bryn Mawr, Pa., recently broke ground for the $32 million, 141,000 square foot Bryn Mawr Medical Arts Pavilion.
? White Plains, N.Y.-based private equity firm Seavest Inc. and developer Trammell Crow Co. broke ground in recent weeks on a $13.6 million, two-story, 62,454 square foot MOB in Warwick, R.I., on the campus of Kent Hospital, about 15 miles from Providence.
? Indianapolis-based Duke Realty recently started construction of an 87,000 outpatient facility on the Raleigh, N.C., campus of WakeMed Health & Hospitals.
? Denver-based NexCore Group recently started development on an $18 million, 60,000 square foot medical office building (MOB) on the campus of Saint Agnes Hospital in Baltimore.

A sampling of the inpatient projects detailed in the current edition of HREI involve RegionalCare Hospital Partners in Alabama, Sisters of Mercy Health Care in Missouri, Kapi’olani Medical Center for Women & Children in Honolulu, and Lowell (Mass.) General Hospital, to name just a few.

“A few dozen projects are not definitive proof of a sustained market recovery, but the recent flurry of activity certainly suggests that healthcare real estate development and investment might be gaining strength,” says John B. Mugford, Editor of HREI.

“We certainly observed a slowdown in healthcare real estate activity from mid-2008 through most of 2010, and recent MOB sales volume has been inconsistent,” Mr. Mugford acknowledges. “But the healthcare real estate niche outperformed most other commercial real estate sectors during the recession, and the recent volume of activity seems to be accelerating.

“In addition to the transactions and projects mentioned in our current edition, we are already working on numerous articles about other new deals and developments that will be published in upcoming editions of Healthcare Real Estate Insights.”

About Healthcare Real Estate Insights

Launched in January 2003, Healthcare Real Estate Insights has come to be recognized as the most trusted independent source of news and trend information in the healthcare real estate development, financing and investment sector. This monthly, national, B2B newsletter offers sophisticated players the most comprehensive coverage in the industry available anywhere. For more information or to subscribe, please visit us at http://www.hreinsights.com.

]]> Pharma Now Has the Ability to Access Real-Time Product Launch Data Via an Innovative Technology Platform

InCrowd provides the life sciences industry with access to real-time data. The do-it-yourself platform is breaking the chain of wait-for-it data and forever changing how market research professionals access their target markets.

Boston, MA (PRWEB) November 01, 2011

InCrowd has developed an innovative do-it-yourself market research platform providing the global life sciences industry with immediate market feedback. The disruptive nature of the platform, delivering real-time vs. wait-for-it data, is forever changing how market research professionals access their target markets.
    Market feedback in hours vs. 2-6 weeks for results     24/7 InCrowd platform eliminates research set-up time     Capitalizes on the time-value of data     Crowdsourcing yields immediate insights

The InCrowd platform connects pharmaceutical, medical device and life science companies with Crowds of screened and targeted health care professionals via propriety mobile and browser-based technologies. This specialized crowdsourcing provides answers within hours, even minutes. The do-it-yourself aspect of the platform ensures easy and rapid question creation; while the single question format facilitates rapid Crowd response.

Janet Kosloff, Co-Founder and CEO of InCrowd, explains the value of real-time data in the highly competitive life sciences industry. “Our goal at InCrowd is to provide our clients with a competitive advantage. Their business rivals can continue down the path of traditional market research, while InCrowd clients access previously untapped data in-the moment.”

She goes on to say, “Imagine the power of crowdsourcing a group of physicians within hours of product launch and initial detailing by your sales representatives. You now have access to market information that was previously untappable for several weeks. Think of the advantages your company can realize simply by accessing and acting on real-time data. We see this is a game changer for our clients.”

ABOUT INCROWD

InCrowd was launched in March of 2010 by Janet Kosloff, CEO, Diane Hayes, PhD, President and Kathleen Poulos, Senior Vice President. Together the co-founders bring over 60 years of medical, business technology and market research knowledge to the company. InCrowd provides the life sciences industry with immediate access to health care professionals through a do-it-yourself platform designed to capture market insights. The disruptive innovation behind the InCrowd platform is breaking the chain of wait-for-it data and creating a link to knowledge in the moment.

For more information watch InCrowd’s Client Tutorial

CONTACT

Kathleen Poulos
Senior Vice President
Kathleen(dot)Poulos(at)InCrowdNow(dot)com
949.285.6375

]]> Applied Food Sciences Successfully Concludes Patent Infringement Case

Applied Food Sciences, Inc. has favorably concluded a patent dispute with Dajomi Brands, LLC, the former marketers of NOHO "The Hangover Defense"™ shot, that required Dajomi to cease making and distributing the products that allegedly infringed Applied Food Sciences, Inc.'s patent. Its patent for the use of glucarate and its derivatives such as glucuronolactone, a popular ingredient in energy drinks, for the reduction of negative symptoms associated with alcohol ingestion. U.S. Patent No. 7,662,863.

Austin, TX (PRWEB) July 11, 2011

Applied Food Sciences, Inc. has favorably concluded a patent dispute with Dajomi Brands, LLC, the former marketers of NOHO “The Hangover Defense”™ shot, that required Dajomi to cease making and distributing the products that allegedly infringed Applied Food Sciences, Inc.’s patent.

Applied Food Sciences, Inc. brought a lawsuit, case 1:2010cv00767, in the United States District Court for the Eastern District of Texas against the former marketer of NOHO™, stating they were infringing its patent for the use of glucarate and its derivatives such as glucuronolactone, a popular ingredient in energy drinks, for the reduction of negative symptoms associated with alcohol ingestion. U.S. Patent No. 7,662,863.

A U.S. District Judge issued a final judgment and permanent injunction against Dajomi Brands, LLC. The validity or enforceability of the patent was not disputed by Dajomi Brands, LLC. The defendant was enjoined from making, using, offering to sell, selling, or otherwise distributing within the United States, or importing into the United States, infringing products.

“This judgment further validates the value of our technology and demonstrates that we will vigorously enforce our rights under the patent. We are interested in partnering with other marketers of detoxification products but we want them to properly license our technology if they want to make claims related to hangover prevention.” said Loretta M. Zapp, Applied Food Sciences, Inc.’s CEO.

Applied Food Sciences, Inc.’s patent covers several ingredients and products, including their own product, GTOX® Hangover Shot which is specifically formulated for preventing hangovers. Austin, Texas-based Applied Food Sciences is a health and wellness organization that specializes in providing nutritional solutions for the food, beverage and supplement industries. For more information visit website gtoxnow.com, http://www.appliedfoods.com or call 1-800-345-9666.